BioCentury
ARTICLE | Clinical News

Rozrolimupab: Final Phase II data

August 27, 2012 7:00 AM UTC

Previously reported data from a dose-escalation, open-label, international Phase II trial of rozrolimupab in 61 RhD-positive, non-splenectomized patients with ITP were published in Blood. The data sho...